SCHEMBL8697275

SCHEMBL8697275

CCOC(=O)Oc1[nH]c2c3ccccc3n(C)c2c1-c1ccc(OC)cc1OCC(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.42
ADORA2B P29275 2/20 0.40
MAPT P10636 2/20 0.39
ALDH1A1 P00352 1/20 0.39
PKM P14618 1/20 0.39
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PRKCA P17252 1/20 0.37
GSK3B P49841 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
EDNRB P24530 1/20 0.36
MYLK Q15746 1/20 0.36
NTRK1 P04629 2/20 0.36
HRH2 P25021 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
PSEN1 P49768 3/20 0.35
PSEN2 P49810 3/20 0.35
APH1B Q8WW43 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8697591 0.94 PTPN1 (0.46) PTPN1ADORA2BMAPTALDH1A1POLB
SCHEMBL8697633 0.92 POLB (0.37) PTPN1POLBPRKCAGSK3BEDNRB
SCHEMBL8698594 0.91 PTPN1 (0.39) PTPN1ADORA2BMAPTALDH1A1POLB
SCHEMBL8702544 0.88 EDNRB (0.38) PTPN1POLBSMN1; SMN2PRKCAGSK3B
SCHEMBL8697402 0.88 NTRK1 (0.39) MAPTALDH1A1PRKCAGSK3BMYLK
SCHEMBL8704430 0.84 EDNRB (0.34) PTPN1ADORA2BMAPTSMN1; SMN2PRKCA
SCHEMBL8696580 0.82 ALDH1A1 (0.46) MAPTALDH1A1POLBSMN1; SMN2
SCHEMBL8591475 0.80 PTPN1 (0.42) PTPN1ADORA2BMAPTALDH1A1POLB
SCHEMBL8697199 0.78 EDNRB (0.39) PTPN1EDNRB
SCHEMBL8550982 0.77 CTSV (0.44) PTPN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998042709-A1 ENDOTHELIN-RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 1998-10-01 WO disclosed